Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

被引:173
作者
Matsuoka, M [1 ]
Ogata, N [1 ]
Otsuji, T [1 ]
Nishimura, T [1 ]
Takahashi, K [1 ]
Matsumura, M [1 ]
机构
[1] Kansai Med Univ, Dept Ophthalmol, Osaka 5708507, Japan
关键词
D O I
10.1136/bjo.2003.032466
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims: To determine whether pigment epithelium derived factor (PEDF), a protein that inhibits angiogenesis, is expressed in human choroidal neovascular membranes (CNVMs) and in tissues from an eye with polypoidal choroidal vasculopathy (PCV). In addition, to compare the expression of PEDF with that of vascular endothelial growth factor (VEGF), a known stimulator of angiogenesis, in these tissues. Methods: CNVMs, associated with age related macular degeneration (AMD), angioid streaks, and PCV, were obtained during surgery. The expression of PEDF and VEGF in the excised subretinal fibrovascular membranes was determined by immunohistochemistry. Results: PEDF and VEGF were strongly expressed in the vascular endothelial cells and retinal pigment epithelial (RPE) cells in the CNVMs where numerous new vessels were prominent (clinically active CNVMs). On the other hand, immunoreactivity for PEDF and VEGF was weak in the new vessels where fibrosis was prominent (clinically quiescent CNVMs). However, the RPE cells were still positive for PEDF and VEGF. The specimens from the eye with PCV also showed strong expression of PEDF and VEGF in the vascular endothelial cells and the RPE cells. Conclusion: Because PEDF is an inhibitor of ocular angiogenesis and an inhibitor of ocular cell proliferation, our results suggest that PEDF along with VEGF may modulate the formation of subfoveal fibrovascular membranes.
引用
收藏
页码:809 / 815
页数:7
相关论文
共 42 条
[1]   SYNTHESIS AND SECRETION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR BY HUMAN RETINAL-PIGMENT EPITHELIAL-CELLS [J].
ADAMIS, AP ;
SHIMA, DT ;
YEO, KT ;
YEO, TK ;
BROWN, LF ;
BERSE, B ;
DAMORE, PA ;
FOLKMAN, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (02) :631-638
[2]  
AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178
[3]  
AMIN RH, 1995, INVEST OPHTH VIS SCI, V36, pS2565
[4]  
BOUCK N, 1990, CANCER CELL-MON REV, V2, P179
[5]  
DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974
[6]   Pigment epithelium-derived factor: A potent inhibitor of angiogenesis [J].
Dawson, DW ;
Volpert, OV ;
Gillis, P ;
Crawford, SE ;
Xu, HJ ;
Benedict, W ;
Bouck, NP .
SCIENCE, 1999, 285 (5425) :245-248
[7]  
Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821
[8]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[9]   Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes [J].
Frank, RN ;
Amin, RH ;
Eliott, D ;
Puklin, JE ;
Abrams, GW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 122 (03) :393-403
[10]   Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor - A possible mechanism for the anti-angiogenic activity of plasminogen kringle 5 [J].
Gao, GQ ;
Li, Y ;
Gee, S ;
Dudley, A ;
Fant, J ;
Crosson, C ;
Ma, JX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :9492-9497